Secondary syphilitic female pelvic disease
ICD-10 A51.42 is a billable code used to indicate a diagnosis of secondary syphilitic female pelvic disease.
Secondary syphilitic female pelvic disease is a manifestation of secondary syphilis, which occurs when Treponema pallidum, the bacterium responsible for syphilis, spreads throughout the body after the initial infection. In women, this can lead to pelvic inflammatory disease (PID), characterized by inflammation of the female reproductive organs, including the uterus, fallopian tubes, and ovaries. Symptoms may include pelvic pain, abnormal vaginal discharge, fever, and dyspareunia. Diagnosis is typically made through serological testing for syphilis, including non-treponemal tests (e.g., RPR, VDRL) and treponemal tests (e.g., FTA-ABS). Treatment involves the administration of benzathine penicillin G, which is the first-line therapy for syphilis. It is crucial to conduct contact tracing to identify and treat sexual partners to prevent reinfection and further transmission. Regular follow-up is necessary to monitor treatment efficacy and manage any complications that may arise.
Detailed history of sexual activity, serological test results, and treatment plans.
Patients presenting with pelvic pain and a history of syphilis.
Need for comprehensive STI screening and management of co-infections.
Pelvic examination findings, imaging results, and treatment response.
Women with PID symptoms and a positive syphilis test.
Awareness of the implications of STIs on reproductive health.
Used when testing for syphilis in patients with pelvic symptoms.
Document the reason for testing and any relevant clinical findings.
Infectious disease specialists should ensure comprehensive STI screening.
Common symptoms include pelvic pain, abnormal vaginal discharge, fever, and dyspareunia. Patients may also experience systemic symptoms such as rash or lymphadenopathy.
